Company Overview - Silo Pharma, Inc. is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company focused on addressing underserved conditions such as stress-induced psychiatric disorders, chronic pain, and central nervous system diseases [4] - The company's portfolio includes innovative programs targeting PTSD, fibromyalgia, chronic pain, Alzheimer's disease, and multiple sclerosis, developed in collaboration with leading universities and laboratories [4] Investment in DeSci - Silo Pharma has made an initial purchase of ResearchCoin (RSC), the native token of ResearchHub, as part of its strategy to expand its digital assets treasury and capture long-term value from emerging multi-chain opportunities [1][2] - The investment in RSC aligns with the growing decentralized science (DeSci) movement, which emphasizes the use of blockchain technologies and token-based economics to modernize scientific research and collaboration [2] DeSci Movement - DeSci represents a transformative growth opportunity in the scientific research sector, with the potential to unlock a trillion-dollar global research economy currently tied up in grants, universities, and pharmaceutical pipelines [3] - By tokenizing research funding and intellectual property, DeSci can create profit opportunities years before traditional biotech exits, allowing investors to capture upside earlier and access new growth avenues in the biotech sector [3]